Literature DB >> 11127208

Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.

H W Woitge1, A Knothe, K Witte, H Schmidt-Gayk, R Ziegler, B Lemmer, M J Seibel.   

Abstract

Recent studies suggest a circannual pattern of bone turnover. To further investigate the underlying mechanisms, 41 healthy subjects (25-80 years old) living in a southwestern German city were studied prospectively over a period of 18 months. Participants were examined every 4 weeks, and blood and urine samples were obtained on each visit. The following parameters were measured: serum 25-hydroxyvitamin D3 [25(OH)D3], 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and parathyroid hormone (PTH), as regulators, and serum total alkaline phosphatase (TAP), bone-specific alkaline phosphatase (BAP), urinary total pyridinoline (PYD), deoxypyridinoline (DPD), and the aminoterminal telopeptide of collagen type I (NTX), as biochemical markers of bone turnover. The presence of significant circannual rhythms for the various markers was tested using the Pharmfit method. In the total group, 25(OH)D3, 1,25(OH)2D3, and PTH as well as BAP, PYD, DPD, and NTX showed a significant seasonal variation. 25(OH)D3 revealed the highest amplitude (38.0%) with an acrophase in August. Levels of the biochemical markers and of PTH were highest in winter with amplitudes of up to 17.7% (DPD). Results were most pronounced in premenopausal women, in subjects <50 years of age, and in subjects who did show a significant individual rhythm in 25(OH)D3 levels. No differences were found regarding other anthropometric or life style factors. Correlation analyses revealed strongest associations between the amplitudes of a vitamin D metabolite and a biochemical marker in premenopausal women. We conclude that specific markers of bone turnover show significant circannual rhythms. These changes are related directly to variations in the hormonal regulation of skeletal homeostasis. In postmenopausal women and in men, other effects may superimpose the circannual variation of biomarkers of bone turnover.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127208     DOI: 10.1359/jbmr.2000.15.12.2443

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

Review 1.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

2.  Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.

Authors:  Piergiorgio Bolasco
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

Review 3.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

4.  Bone measurements of infants in the first 3 months of life by quantitative ultrasound: the influence of gestational age, season, and postnatal age.

Authors:  Xiang-Peng Liao; Wei-Li Zhang; Jiamin He; Jian-Hua Sun; Ping Huang
Journal:  Pediatr Radiol       Date:  2005-05-12

5.  Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study.

Authors:  N Saquib; D von Mühlen; C F Garland; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2006-09-12       Impact factor: 4.507

6.  Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.

Authors:  Christian Bieglmayer; Hans Peter Dimai; Rudolf Wolfgang Gasser; Stefan Kudlacek; Barbara Obermayer-Pietsch; Wolfgang Woloszczuk; Elisabeth Zwettler; Andrea Griesmacher
Journal:  Wien Med Wochenschr       Date:  2012-08-14

7.  Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael C Sachs; Abigail Shoben; Gregory P Levin; Cassy Robinson-Cohen; Andrew N Hoofnagle; Nancy Swords-Jenny; Joachim H Ix; Matthew Budoff; Pamela L Lutsey; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Am J Clin Nutr       Date:  2013-04-24       Impact factor: 7.045

8.  High Prevalence of Vitamin D Insufficiency in Farming and Nonfarming Populations in South Dakota: Associations With Parathyroid Hormone, Body Fat, and Bone Density.

Authors:  Lee Weidauer; Lacey McCormack; Brittany Gorres-Martens; Bonny Specker
Journal:  Top Clin Nutr       Date:  2016 Jul-Sep       Impact factor: 0.508

Review 9.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

Review 10.  Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health.

Authors:  Cees Vermeer; Martin J Shearer; Armin Zittermann; Caroline Bolton-Smith; Pawel Szulc; Stephen Hodges; Paul Walter; Walter Rambeck; Elisabeth Stöcklin; Peter Weber
Journal:  Eur J Nutr       Date:  2004-02-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.